滚动资讯
Thermo FisherIs Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Rebound? - simplywall.st10x Genomics Blog10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AILonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract strength enough for steady U.S. inves - AD HOC NEWS10x Genomics Blog10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - PR Newswire10x Genomics Blog10x Genomics Unveils Atera Spatial Platform at AACR Meeting - Genetic Engineering and Biotechnology News10x Genomics BlogOvervalued Tech Stocks? Texas Instruments, Jabil, 10x Genomics Face Scrutiny - News and Statistics - IndexBoxAgilentAgilent Stock Performance & Valuation Analysis 2026 | Business Review - News and Statistics - IndexBoxLonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract dominance strong enough to unlock new - AD HOC NEWSThermo FisherThermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler - BioSpectrum IndiaLonza NewsLonza Group AG stock (CH0013841017): Is biopharma contract demand strong enough to drive sustained u - AD HOC NEWSThermo FisherNinety One North America Inc. Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeatFierceBiotechAACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
Lonza News 2026年4月19日

Lonza Group AG stock (CH0013841017): Is its biopharma contract strength enough for steady U.S. inves - AD HOC NEWS

Lonza Group AG stock (CH0013841017): Is its biopharma contract strength enough for steady U.S. inves - AD HOC NEWS

原文
暂时没有全文，请查看原始来源。